TokenPost topic
1 TokenPost story is tagged Corcept. The newest appear first.
The trial showed significant results for both progression-free and overall survival. Genmab plans to discuss next steps with regulators; its shares rose 9.48% at the Oct. 23 close.
Oct 24, 2026, 6:01 AM EDT · Business
